| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| OUTPAT | OUTPAT_ICD10(C811) | Nodular sclerosis | 425 | |
| OUTPAT | OUTPAT_ICD10(C819) | Hodgkin's disease, unspecified | 275 | |
| INPAT | INPAT_ICD10(C811) | Nodular sclerosis | 259 | |
| INPAT | INPAT_ICD10(C819) | Hodgkin's disease, unspecified | 176 | |
| OUTPAT | OUTPAT_ICD10(C810) | Lymphocytic predominance | 156 | |
| OUTPAT | OUTPAT_ICD10(C812) | Mixed cellularity | 124 | |
| OUTPAT | OUTPAT_ICD10(C817) | Other Hodgkin's disease | 117 | |
| INPAT | INPAT_ICD10(C810) | Lymphocytic predominance | 78 | |
| INPAT | INPAT_ICD10(C812) | Mixed cellularity | 73 | |
| INPAT | INPAT_ICD10(C817) | Other Hodgkin's disease | 57 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C811) | Nodular sclerosis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 56 | |
| INPAT | INPAT_ICD9(2015X) | Hodgkin's disease, Nodular sclerosis | 47 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C819) | Hodgkin's disease, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 37 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C81) | Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 31 | |
| INPAT | INPAT_ICD9(2019X) | Hodgkin's disease, unspecified type | 28 | |
| OUTPAT | OUTPAT_ICD10(C813) | Lymphocytic depletion | 23 | |
| INPAT | INPAT_ICD9(2016A) | Hodgkin's disease, mixed cellularity | 20 | |
| INPAT | INPAT_ICD9(2014A) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 19 | |
| DEATH | DEATH_ICD10(C811) | Nodular sclerosis | 18 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C817) | Other Hodgkin's disease. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 16 | |
| INPAT | INPAT_ICD9(2015A) | Hodgkin's disease, Nodular sclerosis | 15 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C810) | Lymphocytic predominance. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 12 | |
| PRIM_OUT | PRIM_OUT_NOT_USED_ICD10(C812) | Mixed cellularity. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! | 12 | |
| INPAT | INPAT_ICD10(C813) | Lymphocytic depletion | 11 | |
| DEATH | DEATH_ICD10(C819) | Hodgkin's disease, unspecified | 10 | |
| INPAT | INPAT_ICD9(2014X) | Hodgkin's disease, Lymphocytic-histiocytic predominance | 7 | |
| INPAT | INPAT_ICD9(2017X) | Hodgkin's disease, Lymphocytic depletion | 7 | |
| OUTPAT | OUTPAT_ICD10(C81) | Hodgkin's disease | 7 | |
| DEATH | DEATH_ICD10(C812) | Mixed cellularity | 5 |